Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial.

Simó R, Hernández C, Porta M, Bandello F, Grauslund J, Harding SP, Aldington SJ, Egan C, Frydkjaer-Olsen U, García-Arumí J, Gibson J, Lang GE, Lattanzio R, Massin P, Midena E, Ponsati B, Ribeiro L, Scanlon P, Lobo C, Costa MÂ, Cunha-Vaz J; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).

Diabetes. 2018 Nov 2. pii: db180682. doi: 10.2337/db18-0682. [Epub ahead of print]

PMID:
30389750
2.

The impact of fatigue on the non-technical skills performance of critical care air ambulance clinicians.

Myers JA, Powell DMC, Aldington S, Sim D, Psirides A, Hathaway K, Haney MF.

Acta Anaesthesiol Scand. 2017 Nov;61(10):1305-1313. doi: 10.1111/aas.12994. Epub 2017 Sep 13.

PMID:
28901538
3.

Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project.

Santos AR, Ribeiro L, Bandello F, Lattanzio R, Egan C, Frydkjaer-Olsen U, García-Arumí J, Gibson J, Grauslund J, Harding SP, Lang GE, Massin P, Midena E, Scanlon P, Aldington SJ, Simão S, Schwartz C, Ponsati B, Porta M, Costa MÂ, Hernández C, Cunha-Vaz J, Simó R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).

Diabetes. 2017 Sep;66(9):2503-2510. doi: 10.2337/db16-1453. Epub 2017 Jun 29.

4.

Sing Your Lungs Out-a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study.

McNaughton A, Weatherall M, Williams M, McNaughton H, Aldington S, Williams G, Beasley R.

BMJ Open. 2017 Jan 24;7(1):e014151. doi: 10.1136/bmjopen-2016-014151.

5.

Association of Retinopathy and Retinal Microvascular Abnormalities With Stroke and Cerebrovascular Disease.

Hughes AD, Falaschetti E, Witt N, Wijetunge S, Thom SA, Tillin T, Aldington SJ, Chaturvedi N.

Stroke. 2016 Nov;47(11):2862-2864. Epub 2016 Oct 11.

6.

Sing Your Lungs Out: a qualitative study of a community singing group for people with chronic obstructive pulmonary disease (COPD).

McNaughton A, Aldington S, Williams G, Levack WM.

BMJ Open. 2016 Sep 20;6(9):e012521. doi: 10.1136/bmjopen-2016-012521.

7.

Non-technical skills evaluation in the critical care air ambulance environment: introduction of an adapted rating instrument--an observational study.

Myers JA, Powell DM, Psirides A, Hathaway K, Aldington S, Haney MF.

Scand J Trauma Resusc Emerg Med. 2016 Mar 8;24:24. doi: 10.1186/s13049-016-0216-5.

8.

The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.

Oke JL, Stratton IM, Aldington SJ, Stevens RJ, Scanlon PH.

Diabet Med. 2016 Jul;33(7):896-903. doi: 10.1111/dme.13053. Epub 2016 Jan 10.

9.

Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.

Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, Gazis A, Stratton IM.

Health Technol Assess. 2015 Sep;19(74):1-116. doi: 10.3310/hta19740.

10.

Calcium scores in the risk assessment of an asymptomatic population: implications for airline pilots.

Wirawan IM, Wu R, Abernethy M, Aldington S, Larsen PD.

Aviat Space Environ Med. 2014 Aug;85(8):812-7. doi: 10.3357/ASEM.3904.2014.

PMID:
25199122
11.

Epidemiological issues in diabetic retinopathy.

Scanlon PH, Aldington SJ, Stratton IM.

Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):293-300. doi: 10.4103/0974-9233.120007. Review.

12.

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.

Scanlon PH, Aldington SJ, Stratton IM.

Diabet Med. 2014 Apr;31(4):439-42. doi: 10.1111/dme.12313. Epub 2013 Oct 17.

13.

Updating diabetic retinopathy screening lists using automatic extraction from GP patient records.

Scanlon PH, Provins EK, Craske S, Chave SJ, Aldington SJ, Martin CN, Stratton IM.

J Med Screen. 2013;20(3):111-7. doi: 10.1177/0969141313505747. Epub 2013 Sep 24.

PMID:
24064544
14.

Risk stratification for diabetic eye screening.

Stratton IM, Aldington SJ.

Diabetologia. 2014 Jan;57(1):259. doi: 10.1007/s00125-013-3060-4. Epub 2013 Sep 22. No abstract available.

PMID:
24057137
15.

Cardiovascular investigations of airline pilots with excessive cardiovascular risk.

Wirawan IM, Aldington S, Griffiths RF, Ellis CJ, Larsen PD.

Aviat Space Environ Med. 2013 Jun;84(6):608-12.

PMID:
23745289
16.

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.

Scanlon PH, Stratton IM, Histed M, Chave SJ, Aldington SJ.

Acta Ophthalmol. 2013 Aug;91(5):e335-9. doi: 10.1111/aos.12074. Epub 2013 Apr 1.

17.

A simple risk stratification for time to development of sight-threatening diabetic retinopathy.

Stratton IM, Aldington SJ, Taylor DJ, Adler AI, Scanlon PH.

Diabetes Care. 2013 Mar;36(3):580-5. doi: 10.2337/dc12-0625. Epub 2012 Nov 12.

18.

A study of airline pilot morbidity.

Sykes AJ, Larsen PD, Griffiths RF, Aldington S.

Aviat Space Environ Med. 2012 Oct;83(10):1001-5.

PMID:
23066624
19.

Cardiovascular risk score and cardiovascular events among airline pilots: a case-control study.

Wirawan IM, Larsen PD, Aldington S, Griffiths RF, Ellis CJ.

Aviat Space Environ Med. 2012 May;83(5):465-71.

PMID:
22606861
20.

Incidental findings from lung CT scans: implications for research.

Aldington S, Shirtcliffe P, Nowitz M, Kingzett-Taylor A, Tweed M, Weatherall M, Soriano JB, Beasley R.

J Med Imaging Radiat Oncol. 2011 Feb;55(1):20-5. doi: 10.1111/j.1754-9485.2010.02224.x.

PMID:
21382185
21.

Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.

Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Aldington S, Chaturvedi N.

Diabet Med. 2011 Mar;28(3):345-51. doi: 10.1111/j.1464-5491.2010.03210.x.

PMID:
21309844
22.

Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.

Murray CS, Custovic A, Lowe LA, Aldington S, Williams M, Beasley R, Woodcock A.

Allergy Asthma Proc. 2010 Sep-Oct;31(5):415-21. doi: 10.2500/aap.2010.31.3362.

PMID:
20929609
23.

Distinct clinical phenotypes of airways disease defined by cluster analysis.

Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R.

Eur Respir J. 2009 Oct;34(4):812-8. doi: 10.1183/09031936.00174408. Epub 2009 Apr 8.

24.

Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.

Thompson I, Williams G, Caldwell B, Aldington S, Dickson S, Lucas N, McDowall J, Weatherall M, Robinson G, Beasley R.

J Psychopharmacol. 2010 Sep;24(9):1299-308. doi: 10.1177/0269881109102608. Epub 2009 Mar 27.

PMID:
19329546
25.

Proportional classifications of COPD phenotypes.

Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, Hansell AL, Nowitz MR, McNaughton AA, Soriano JB, Beasley RW.

Thorax. 2008 Sep;63(9):761-7. doi: 10.1136/thx.2007.089193. Erratum in: Thorax. 2015 Sep;70(9):905. Thorax. 2014 Jul;69(7):672.

26.

A case-control study of seated immobility at work as a risk factor for venous thromboembolism.

West J, Perrin K, Aldington S, Weatherall M, Beasley R.

J R Soc Med. 2008 May;101(5):237-43. doi: 10.1258/jrsm.2008.070366.

27.

Cannabis use and cancer of the head and neck: case-control study.

Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R; Cannabis and Respiratory Disease Research Group.

Otolaryngol Head Neck Surg. 2008 Mar;138(3):374-80. doi: 10.1016/j.otohns.2007.12.002.

28.

Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission.

Aldington S, Pritchard A, Perrin K, James K, Wijesinghe M, Beasley R.

Intern Med J. 2008 Feb;38(2):133-5. doi: 10.1111/j.1445-5994.2007.01597.x.

PMID:
18290829
29.

Cannabis use and risk of lung cancer: a case-control study.

Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R; Cannabis and Respiratory Disease Research Group.

Eur Respir J. 2008 Feb;31(2):280-6. doi: 10.1183/09031936.00065707.

30.

Physiological associations of computerized tomography lung density: a factor analysis.

Marsh S, Aldington S, Williams MV, Nowitz M, Kingzett-Taylor A, Weatherall M, Shirtcliffe P, Pritchard A, Beasley R.

Int J Chron Obstruct Pulmon Dis. 2006;1(2):181-7.

31.

Is it time to change the approach to oxygen therapy in the breathless patient?

Beasley R, Aldington S, Robinson G.

Thorax. 2007 Oct;62(10):840-1. No abstract available.

32.

COPD prevalence in a random population survey: a matter of definition.

Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, Aldington S, Muellerova H, Beasley R.

Eur Respir J. 2007 Aug;30(2):232-9.

33.

Effects of cannabis on pulmonary structure, function and symptoms.

Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R.

Thorax. 2007 Dec;62(12):1058-63. Epub 2007 Jul 31. Erratum in: Thorax. 2008 Apr;63(4):385.

34.

Pulmonary function testing in New Zealand: the use and importance of reference ranges.

Marsh S, Aldington S, Williams MV, Weatherall M, Robiony-Rogers D, Jones D, Beasley R.

Respirology. 2007 May;12(3):367-74.

PMID:
17539840
35.

Reference ranges for exhaled nitric oxide derived from a random community survey of adults.

Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A, Weatherall M, Beasley R.

Am J Respir Crit Care Med. 2007 Aug 1;176(3):238-42. Epub 2007 May 3.

PMID:
17478616
36.
37.

Oxygen therapy in myocardial infarction: an historical perspective.

Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D.

J R Soc Med. 2007 Mar;100(3):130-3. Review. No abstract available.

38.

An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma.

Charles T, Quinn D, Weatherall M, Aldington S, Beasley R, Holt S.

J Allergy Clin Immunol. 2007 Apr;119(4):811-6. Epub 2007 Feb 22.

PMID:
17320942
39.

Utility of lung density measurements in the diagnosis of emphysema.

Marsh S, Aldington S, Williams MV, Nowitz MR, Kingzett-Taylor A, Weatherall M, Shirtcliffe PM, McNaughton AA, Pritchard A, Beasley R.

Respir Med. 2007 Jul;101(7):1512-20. Epub 2007 Feb 20.

40.

Scale-up of monoclonal antibody purification processes.

Aldington S, Bonnerjea J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):64-78. Epub 2007 Jan 16. Review.

PMID:
17224311
41.

Magnesium in the treatment of asthma.

Beasley R, Aldington S.

Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):107-10. Review.

PMID:
17218820
42.

External validity of randomized controlled trials in COPD.

Travers J, Marsh S, Caldwell B, Williams M, Aldington S, Weatherall M, Shirtcliffe P, Beasley R.

Respir Med. 2007 Jun;101(6):1313-20. Epub 2006 Nov 17.

43.

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R.

Thorax. 2007 Mar;62(3):219-23. Epub 2006 Nov 14.

44.

Complete reference ranges for pulmonary function tests from a single New Zealand population.

Marsh S, Aldington S, Williams M, Weatherall M, Shirtcliffe P, McNaughton A, Pritchard A, Beasley R.

N Z Med J. 2006 Oct 27;119(1244):U2281. Erratum in: N Z Med J. 2007;120(1254):U2551.

PMID:
17072356
45.

Smoking and COPD: What really are the risks?

Marsh S, Aldington S, Shirtcliffe P, Weatherall M, Beasley R.

Eur Respir J. 2006 Oct;28(4):883-4. No abstract available.

46.
47.

Improving the use and interpretation of diagnostic tests in pulmonary embolism.

Aldington S, Robinson G, Beasley R.

N Z Med J. 2006 Jul 7;119(1237):U2057. No abstract available.

PMID:
16862203
48.

Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?

Weatherall M, Aldington S, Caldwell B, Beasley R.

J R Soc Med. 2006 Jun;99(6):275-6. No abstract available.

49.

Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.

Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R.

J R Soc Med. 2006 Mar;99(3):132-40. Review.

50.

Epidemiology and costs of chronic obstructive pulmonary disease.

Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R.

Eur Respir J. 2006 Jan;27(1):188-207. Review. No abstract available.

Supplemental Content

Loading ...
Support Center